Black Americans are being diagnosed with schizophrenia at rates up to four times higher than White Americans, and researchers warn that racial bias may be causing doctors to overlook other mental health conditions that could better explain their symptoms.
A research analysis by The Schiller Kessler Group highlights the troubling disparity, identifying schizophrenia misdiagnosis as a major concern for Black patients navigating the American healthcare system.
The analysis describes Black patients as up to four times more likely to be misdiagnosed with schizophrenia. However, the underlying medical research establishes that Black patients receive schizophrenia diagnoses at rates up to three to four times higher than White patients. The exact proportion of those diagnoses that are incorrect remains uncertain.
That distinction does not diminish the problem. Multiple studies have found that clinicians sometimes interpret psychiatric symptoms differently depending on a patient’s race, potentially leading Black people to receive diagnoses that overlook depression, bipolar disorder, or other underlying conditions.
A 2018 meta-analysis published in the Journal of Abnormal Psychology examined 55 studies and found that Black Americans had approximately 2.4 times the odds of receiving a schizophrenia diagnosis compared with White Americans.
A separate 2023 review published in Frontiers in Psychiatry documented research showing schizophrenia spectrum diagnosis rates three to four times higher among Black communities.
Researchers have identified clinician bias, cultural misunderstandings, unequal access to care, and differences in exposure to social stressors as potential contributors.
One of the most revealing findings comes from Rutgers University researchers, who examined medical records from 1,657 patients receiving treatment at community behavioral health clinics.
Their 2019 study included 599 Black patients and 1,058 non-Latino White patients. Researchers found that Black patients diagnosed with schizophrenia were significantly more likely to screen positive for major depression than White patients with the same diagnosis.
The findings suggested that clinicians were giving greater weight to symptoms associated with psychosis while paying insufficient attention to symptoms of depression among Black patients.
Michael Gara, a Rutgers psychiatry professor involved in the study, explained that doctors must rule out other potential causes of psychiatric symptoms before diagnosing schizophrenia.
He also warned that clinicians have historically placed too much emphasis on psychotic symptoms in Black patients, even when depressive symptoms suggest another explanation.
That difference matters because schizophrenia, bipolar disorder, and major depression with psychotic features can involve overlapping symptoms, but they are not interchangeable diagnoses.
Someone experiencing hallucinations, for example, may also have severe depression or a mood disorder that requires a different treatment plan. According to the Rutgers research, failing to properly evaluate those mood symptoms can result in patients receiving the wrong diagnosis.
The consequences can follow someone for years.
Gara warned that patients misdiagnosed with schizophrenia may not receive appropriate treatment for their actual condition. Medications used to manage schizophrenia can also cause significant side effects, including weight gain and diabetes.
An inaccurate diagnosis can additionally affect how future providers interpret a patient’s symptoms, potentially influencing treatment decisions long after the original evaluation.
More recent research suggests the issue may begin with how healthcare workers describe patients in their medical records.
An April 2026 research preprint examined psychiatric records involving 29,005 emergency department patients with diagnoses including schizophrenia, anxiety, depression, bipolar disorder, and trauma-related conditions.
Researchers found that patients whose medical notes contained a higher proportion of negative descriptions had increased odds of receiving a schizophrenia diagnosis. Black male patients with high levels of negative language in their records showed particularly elevated diagnostic odds.
The study has not yet undergone journal peer review, and its findings do not prove that negative descriptions caused incorrect diagnoses. However, they raise additional questions about how a clinician’s perceptions may influence psychiatric assessments.
The National Institute of Mental Health has also documented persistent racial disparities.
A federally funded study examining records from nearly six million Northern California patients between 2009 and 2019 found that Black patients consistently had the highest rates of diagnoses involving both mood-related and other psychotic disorders.
The agency emphasized that researchers must investigate whether those differences reflect actual variations in illness, unconscious bias, misdiagnosis, or unequal access to healthcare.
A 2024 systematic review published in JAMA Psychiatry similarly found racial differences in both schizophrenia diagnoses and reported psychotic experiences. Its authors cautioned that diagnostic bias alone cannot explain every disparity.
Meanwhile, access to mental health care remains another significant obstacle.
According to the U.S. Department of Health and Human Services Office of Minority Health, only 14.7% of Black adults received mental health treatment in 2024, compared with 22.9% of American adults overall.
That means Black adults were approximately 36% less likely than the overall adult population to receive mental health treatment, adding another challenge for people who may already be struggling to obtain accurate assessments.
The broader pattern of medical misdiagnosis extends beyond psychiatric care.
The Schiller Kessler Group’s analysis also cites research showing that paramedics failed to recognize suspected strokes in 34.9% of Black patients later diagnosed with the condition, compared with 31.4% of White patients.
Other findings highlight disparities involving lupus, endometriosis and multiple sclerosis. Black women face substantially higher rates of lupus than White women, while research has found that Black women have approximately half the odds of receiving an endometriosis diagnosis.
For multiple sclerosis, the analysis reports that 38.3% of Black patients had experienced vision loss by the time of diagnosis, compared with 28.6% of White patients.
These conditions involve different medical challenges, but together they demonstrate how unequal diagnosis and delayed recognition remain concerns across healthcare.
The financial consequences are also substantial. The Schiller Kessler Group cites an estimate that diagnostic errors and their consequences account for approximately $870 billion in annual U.S. healthcare spending.
For patients questioning a schizophrenia diagnosis, the Rutgers researchers’ findings support comprehensive screening for depression and careful evaluation of mood symptoms before clinicians settle on a diagnosis. A second psychiatric opinion may also help when symptoms and treatment responses do not match the original assessment.
The larger responsibility, however, belongs to healthcare systems and medical professionals. More culturally informed evaluations, thorough psychiatric histories, and greater awareness of implicit bias could help reduce unnecessary diagnostic disparities.
For Black patients, the concern is not simply that schizophrenia is diagnosed more frequently. It is that a diagnosis can carry major consequences when clinicians fail to consider the full picture.
The research makes clear that recognizing someone’s symptoms is only part of the job. Understanding what those symptoms actually mean, without allowing racial assumptions to shape the answer, is just as important.
